Virbac

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:11 2024-09-06 am EDT			5-day change	1st Jan Change
345.50 ^EUR	-0.29%		-0.58%	-3.89%

Jul. 30	Virbac: up sharply, broker raises his recommendation	CF
Jul. 30	TP ICAP Midcap Upgrades Virbac to Buy	MT

Ex-dividend day for final dividend

June 24, 2024

A final dividend is removed today from 's share.

Latest news about Virbac

Virbac: up sharply, broker raises his recommendation	Jul. 30	CF
TP ICAP Midcap Upgrades Virbac to Buy	Jul. 30	MT
VIRBAC : TP Icap Midcap upgrades to buy	Jul. 30	CF
VIRBAC : Robust Q2 was already baked in after the recent guidance upgrade	Jul. 17
VIRBAC : price target raised by Oddo BHF	Jul. 17	CF
Virbac: 15% sales growth in 1st half-year	Jul. 17	CF
Virbac SA Revises Earnings Guidance for the Fiscal Year 2024	Jul. 16	CI
Virbac SA Announces Non-Audited Consolidated Revenue Results for the Second Quarter and First Half of 2024	Jul. 16	CI
CAC40: will end in the red, despite easing OAT rates	Jul. 08	CF
That's not so bad, is it?	Jul. 08
Virbac CEO to Step Down; Interim Successor Named	Jul. 08	MT
Virbac raises annual targets	Jul. 08	CF
Virbac appoints new CEO and raises sales growth target	Jul. 08	RE
Virbac: Executive Managing Director resigns	Jul. 08	CF
Virbac Sa Announces Chief Executive Officer Changes	Jul. 08	CI
Virbac: now owns 100% of India's Globion	Jul. 02	CF
VIRBAC : Virbac remains an attractive animal healthcare play	May. 03
VIRBAC : A healthy start to 2024; outlook re-iterated	Apr. 17
Virbac: sales up by almost 10% in Q1	Apr. 17	CF
Virbac SA Announces Revenue Results for the First Quarter of 2024	Apr. 16	CI
Virbac: 'strategic' acquisition of Sasaeah in Japan	Apr. 02	CF
Virbac SA acquired Sasaea Holdings Co., Ltd. from ORIX Corporation.	Mar. 31	CI
VIRBAC : Oddo BHF maintains its recommendation on the stock	Mar. 21	CF
CAC40: damage limited despite Kering's fall	Mar. 20	CF
Transcript : Virbac SA, 2023 Earnings Call, Mar 20, 2024	Mar. 20

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).

Employees

5,459

Sector

Pharmaceuticals

Calendar

2024-09-12 - Q2 2024 Earnings Release

Related indices

CAC Mid 60

More about the company